Subject(s)
Cerebral Cortex , Mental Disorders , Nerve Tissue Proteins/metabolism , Animals , Animals, Newborn , Bromodeoxyuridine/metabolism , Cell Proliferation/genetics , Cerebral Cortex/cytology , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , Embryo, Mammalian , Gene Expression Regulation, Developmental/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Mental Disorders/genetics , Mental Disorders/metabolism , Mice , Mice, Transgenic , Nerve Tissue Proteins/genetics , RNA Interference/physiology , TransfectionABSTRACT
We have seen an era of explosive progress in translating neurobiology into etiological understanding of mental disorders for the past 10-15 years. The discovery of Disrupted-in-schizophrenia 1 (DISC1) gene was one of the major driving forces that have contributed to the progress. The finding that DISC1 plays crucial roles in neurodevelopment and synapse regulation clearly underscored the utility and validity of DISC1-related biology in advancing our understanding of pathophysiological processes underlying psychiatric conditions. Despite recent genetic studies that failed to identify DISC1 as a risk gene for sporadic cases of schizophrenia, DISC1 mutant mice, coupled with various environmental stressors, have proven successful in satisfying face validity as models of a wide range of human psychiatric conditions. Investigating mental disorders using these models is expected to further contribute to the circuit-level understanding of the pathological mechanisms, as well as to the development of novel therapeutic strategies in the future.
Subject(s)
Disease Models, Animal , Mental Disorders , Nerve Tissue Proteins/genetics , Animals , Humans , Mental Disorders/genetics , Mental Disorders/metabolism , Mental Disorders/physiopathology , Mice, Mutant Strains , Mice, Transgenic , Translational Research, BiomedicalABSTRACT
NMDA glutamate receptors have key roles in brain development, function and dysfunction. Regulatory roles of D-serine in NMDA receptor-mediated synaptic plasticity have been reported. Nonetheless, it is unclear whether and how neonatal deficits in NMDA-receptor-mediated neurotransmission affect adult brain functions and behavior. Likewise, the role of D-serine during development remains elusive. Here we report behavioral and electrophysiological deficits associated with the frontal cortex in Pick1 knockout mice, which show D-serine deficits in a neonatal- and forebrain-specific manner. The pathological manifestations observed in adult Pick1 mice are rescued by transient neonatal supplementation of D-serine, but not by a similar treatment in adulthood. These results indicate a role for D-serine in neurodevelopment and provide novel insights on how we interpret data of psychiatric genetics, indicating the involvement of genes associated with D-serine synthesis and degradation, as well as how we consider animal models with neonatal application of NMDA receptor antagonists.
Subject(s)
Mental Disorders , Nuclear Proteins/deficiency , Serine/therapeutic use , Signal Transduction/genetics , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Action Potentials/drug effects , Action Potentials/genetics , Age Factors , Animals , Carrier Proteins/genetics , Cell Cycle Proteins , Disease Models, Animal , Dopamine Agonists/pharmacology , Excitatory Amino Acid Antagonists/therapeutic use , Exploratory Behavior/drug effects , Frontal Lobe/pathology , Maze Learning/drug effects , Mental Disorders/drug therapy , Mental Disorders/genetics , Mental Disorders/prevention & control , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/drug effects , Motor Activity/genetics , Neurons/drug effects , Nuclear Proteins/genetics , Prepulse Inhibition/drug effects , Prepulse Inhibition/genetics , Serine/metabolism , Signal Transduction/drug effects , Swimming/psychology , Time FactorsABSTRACT
We report the novel regulation of proteolytic processing of amyloid precursor protein (APP) by DISC1, a major risk factor for psychiatric illnesses, such as depression and schizophrenia. RNAi knockdown of DISC1 in mature primary cortical neurons led to a significant increase in the levels of intracellular α-C-terminal fragment of APP (APP-CTFα) and the corresponding N-terminal-secreted ectodomain product sAPPα. DISC1 knockdown also elicited a significant decrease in the levels of amyloid beta (Aß)42 and Aß40. These aberrant proteolytic events were successfully rescued by co-expression of wild-type DISC1, but not by mutant DISC1 lacking the amino acids required for the interaction with APP, suggesting that APP-DISC1 protein interactions are crucial for the regulation of the C-terminal proteolysis. In a genetically engineered model in which a major full-length DISC1 isoform is depleted, consistent changes in APP processing were seen: an increase in APP-CTFα and decrease in Aß42 and Aß40 levels. Finally, we found that knockdown of DISC1 increased the expression of APP at the cell surface and decreased its internalization. The presented DISC1 mechanism of APP proteolytic processing and Aß peptide generation, which is central to Alzheimer's disease pathology, suggests a novel interface between neurological and psychiatric conditions.
Subject(s)
Amyloid beta-Peptides/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Alzheimer Disease/metabolism , Animals , Brain/metabolism , Cell Membrane/metabolism , Cells, Cultured , Disease Models, Animal , Gene Knockdown Techniques , Humans , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Nerve Tissue Proteins/genetics , Protein Transport , Rats, Sprague-DawleyABSTRACT
Quetiapine is an atypical neuroleptic with a pharmacological profile distinct from classic neuroleptics that function primarily via blockade of dopamine D2 receptors. In the United States, quetiapine is currently approved for treating patients with schizophrenia, major depression and bipolar I disorder. Despite its widespread use, its cellular effects remain elusive. To address possible mechanisms, we chronically treated mice with quetiapine, haloperidol or vehicle and examined quetiapine-specific gene expression change in the frontal cortex. Through microarray analysis, we observed that several groups of genes were differentially expressed upon exposure to quetiapine compared with haloperidol or vehicle; among them, Cdkn1a, the gene encoding p21, exhibited the greatest fold change relative to haloperidol. The quetiapine-induced downregulation of p21/Cdkn1a was confirmed by real-time polymerase chain reaction and in situ hybridization. Consistent with single gene-level analyses, functional group analyses also indicated that gene sets associated with cell cycle/fate were differentially regulated in the quetiapine-treated group. In cortical cell cultures treated with quetiapine, p21/Cdkn1a was significantly downregulated in oligodendrocyte precursor cells and neurons, but not in astrocytes. We propose that cell cycle-associated intervention by quetiapine in the frontal cortex may underlie a unique efficacy of quetiapine compared with typical neuroleptics.
Subject(s)
Antipsychotic Agents/pharmacology , Cell Cycle/drug effects , Dibenzothiazepines/pharmacology , Frontal Lobe/drug effects , Haloperidol/pharmacology , Schizophrenia/metabolism , p21-Activated Kinases/genetics , Analysis of Variance , Animals , Astrocytes/metabolism , Disease Models, Animal , Frontal Lobe/metabolism , Gene Expression , In Situ Hybridization , Male , Methamphetamine/administration & dosage , Mice , Neurons/metabolism , Oligodendroglia/metabolism , Principal Component Analysis , Quetiapine Fumarate , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Schizophrenia/chemically induced , p21-Activated Kinases/metabolismABSTRACT
Significant advances have been made in understanding the role of disrupted-in-schizophrenia-1 (DISC1) in the brain and accumulating findings suggest the possible implication of DISC1 in the regulation of dopamine (DA) function. A mutation in the second exon of DISC1 at L100P leads to the development of schizophrenia-related behavior in mutant mice (DISC1-L100P). We investigated here the role of DA in the expression of schizophrenia-related endophenotypes in the DISC1-L100P genetic mouse model. The mutated DISC1 resulted in facilitation of the psychostimulant effect of amphetamine in DISC1-L100P mutant mice assessed in the open field and prepulse inhibition (PPI) tests. Biochemical studies detected a 2.1-fold increase in the proportion of striatal D receptors without significant changes in DA release in vivo in the striatum of DISC1-L100P mutants in response to the low dose of amphetamine. The D(2) receptor antagonist haloperidol reversed the hyperactivity, PPI and latent inhibition (LI) deficits and blocked the psychostimulant effect of amphetamine in DISC1-L100P mutants. Taken together, our findings show the role of DISC1 in D(2) -related pathophysiological mechanism of schizophrenia, linking DISC1 with well-established DA hypothesis of schizophrenia.
